Cleavage of HPV-16 E6/E7 mRNA mediated by modified 10-23 deoxyribozymes
- PMID: 19732021
- DOI: 10.1089/oli.2009.0193
Cleavage of HPV-16 E6/E7 mRNA mediated by modified 10-23 deoxyribozymes
Abstract
Deoxyribozymes (DXZs) are small oligodeoxynucleotides capable of mediating phosphodiester bond cleavage of a target RNA in a sequence-specific manner. These molecules are a new generation of artificial catalytic nucleic acids currently used to silence many disease-related genes. The present study describes a DXZ (Dz1023-434) directed against the polycistronic mRNA from the E6 and E7 genes of human papillomavirus type 16 (HPV-16), the main etiological agent of cervical cancer. Dz1023-434 showed efficient cleavage against a bona fide antisense window at nt 410-445 within HPV-16 E6/E7 mRNA even in low [Mg(2+)] conditions. Using a genetic analysis as guidance, we introduced diverse chemical modifications within Dz1023-434 catalytic core to produce a stable locked nucleic acid (LNA)-modified DXZ (Dz434-LNA) with significant cleavage activity of full E6/E7 transcripts. Cell culture testing of Dz434-LNA produced a sharp decrement of E6/E7 mRNA levels in HPV-16-positive cells resulting in decreased proliferation and considerable cell death in a specific and dose-dependent manner. No significant effects were observed with inactive or scrambled control DXZs nor from using HPV-negative cells, suggesting catalysis-dependent effect and high specificity. The biological effects of Dz434-LNA suggest a potential use for the treatment of cervical cancer.
Similar articles
-
Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.Gynecol Oncol. 2007 Aug;106(2):299-304. doi: 10.1016/j.ygyno.2007.04.039. Epub 2007 Jun 21. Gynecol Oncol. 2007. PMID: 17586029
-
Inhibition of human papillomavirus expression using DNAzymes.Methods Mol Biol. 2011;764:317-35. doi: 10.1007/978-1-61779-188-8_21. Methods Mol Biol. 2011. PMID: 21748650
-
RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.Apoptosis. 2008 Feb;13(2):273-81. doi: 10.1007/s10495-007-0163-8. Apoptosis. 2008. PMID: 18060502
-
Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins.Rev Med Virol. 2009 Mar;19(2):97-113. doi: 10.1002/rmv.605. Rev Med Virol. 2009. PMID: 19156753 Review.
-
Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses.Antivir Ther. 2003 Aug;8(4):265-78. Antivir Ther. 2003. PMID: 14518695 Review.
Cited by
-
8-17 DNAzyme Silencing Gene Expression in Cells via Cleavage and Antisense.Molecules. 2022 Dec 29;28(1):286. doi: 10.3390/molecules28010286. Molecules. 2022. PMID: 36615479 Free PMC article.
-
DNAzymes: Expanding the Potential of Nucleic Acid Therapeutics.Nucleic Acid Ther. 2023 Jun;33(3):178-192. doi: 10.1089/nat.2022.0066. Epub 2023 Apr 21. Nucleic Acid Ther. 2023. PMID: 37093127 Free PMC article. Review.
-
Studies on the Two Thymine Residues in the Catalytic Core of 10-23 DNAzyme: The Impact on the Catalysis of Their 5-Substituted Functional Groups.Molecules. 2017 Jun 22;22(7):1011. doi: 10.3390/molecules22071011. Molecules. 2017. PMID: 28640218 Free PMC article.
-
A promising nucleic acid therapy drug: DNAzymes and its delivery system.Front Mol Biosci. 2023 Sep 11;10:1270101. doi: 10.3389/fmolb.2023.1270101. eCollection 2023. Front Mol Biosci. 2023. PMID: 37753371 Free PMC article. Review.
-
DNAzymes, Novel Therapeutic Agents in Cancer Therapy: A Review of Concepts to Applications.J Nucleic Acids. 2021 Nov 1;2021:9365081. doi: 10.1155/2021/9365081. eCollection 2021. J Nucleic Acids. 2021. PMID: 34760318 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials